drug

sotagliflozin

1 story · latest Aug 6, 2026

Status: FDA approved May 2023 · NDA216203
Brand: Inpefa
Trials: 1 registered trial in coverage

Relationships

Developed by Lexicon Pharmaceuticals

Timeline

FDA approves labeling supplement for Lexicon's INPEFA (sotagliflozin)

Aug 6Regulatory decisionLexicon Pharmaceuticals sotagliflozin

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.